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 Abstract 
There has been evidence for the effect of anxiety on the neural processing of 
respiratory sensation using the respiratory-related evoked potentials (RREP) elicited 
by inspiratory occlusions. This study tested the RREP elicited by inspiratory 
occlusions in a group of outpatients with Generalized Anxiety Disorder (GAD) and a 
group of healthy controls. We hypothesized that the RREP P3 peak would be 
modulated in the GAD patients.  
A RREP oddball paradigm of 150-msec inspiratory occlusion protocol was 
used in 15 GAD patients and 11 healthy adults with normal lung functions. The RREP 
was recorded with a 40-channel electroencephalography (EEG) system. A minimum 
of 100 occlusions were collected for data analysis.  
We found that the averaged P3 latency of the GAD patients was significantly 
longer than the P3 latency of the healthy controls. In addition, the GAD group showed 
significantly reduced P3 amplitudes compared to the control group. No group 
differences in latency and amplitudes were found for earlier RREP components. 
These results demonstrated that a delayed and reduced attention peak (P3) is 
present in patients with GAD. This suggests that GAD as a disease state modulates the 
higher order processing of respiratory perception.  
 
Keywords: Generalized Anxiety Disorder (GAD), respiratory-related evoked potential, 
respiratory sensation, dyspnea 
  
1. Introduction 
The relationships between possible modulating factors and respiratory interoception 
have gained significant attention in the recent decade because accurate and timely 
perception of respiratory sensation is essential for symptom management in 
respiratory diseases (Janssens et al., 2009; Paulus and Stein, 2010; Rietveld, 1998; 
Tiller et al., 1987; von Leupoldt et al., 2010a; von Leupoldt and Dahme, 2007; von 
Leupoldt et al., 2010b). Interoception as the basis of how an individual feels refers to 
sensing and interpreting one’s physiological state in a context-dependent manner 
(Paulus and Stein, 2010). Indeed, evidence has suggested that “feeling too little” or 
“not sensing in-time” in patients with respiratory diseases could lead to delayed 
treatment (Barnes, 1994; Feldman et al., 2007; Kifle et al., 1997). In contrast, “feeling 
too much” or “sensing too soon” might result in maladaptive responses or behaviors 
such as excessive medication use or activity avoidance (Hayen et al., 2013). 
A significant portion of patients with respiratory diseases including asthma and 
chronic obstructive pulmonary disease (COPD) are diagnosed with comorbid anxiety 
disorders (Maurer et al., 2008; Meuret et al., 2006; Nardi et al., 2009; Scott et al., 
2007). Anxiety is an important modulating factor in respiratory perception because of 
its close association with respiratory diseases (Culpepper, 2009). Past research has 
found that high levels of anxiety and depression were associated with increased 
incidence of asthma (Katon et al., 2004). In addition, respiratory sensations and 
ventilatory changes are diagnostic for anxiety disorders suggesting a relationship 
between respiratory sensory processing and anxiety symptoms. The effects of 
negative affect or anxiety on individuals’ lung functions and respiratory perception 
 have been extensively studied using self-report questionnaires, external loading 
manifolds, and electroencephalogram (EEG) (Bogaerts et al., 2005; Carr et al., 1994; 
Carroll et al., 2011; Giardino et al., 2010; Petersen and Ritz, 2010; Van 
Peski-Oosterbaan et al., 1996; von Leupoldt et al., 2011a; von Leupoldt et al., 2010b). 
Most studies observed that negative affect or anxiety were related to overperception 
of respiratory sensations (von Leupoldt et al., 2013).  
The respiratory-related evoked potentials (RREP) method is a non-invasive technique 
to investigate the neuronal processing of respiratory mechanosensation (Chan and 
Davenport, 2010; von Leupoldt et al., 2013). The method provides high temporal 
resolution for understanding neural activation elicited by respiratory stimulations in 
the higher cortex. It has been found that an inspiratory-occlusion odd-ball paradigm 
can successfully induce the RREP with early (Nf, P1, and N1) and late (P2 and P3) 
peaks, indicative of exogenous and endogenous neural processing aspects, 
respectively, to the given respiratory stimuli. The Nf peak is uniquely observed in the 
RREP and not in other somatosensory or auditory evoked potential literature, and is 
thought to reflect processes in the preparatory aspect of respiratory perception (Chan 
and Davenport, 2010). The P1 peak localized in the somatosensory cortex is 
indicative of sensory information arrival to the higher cortex (Logie et al., 1998). The 
N1 peak following P1 reflects an index of respiratory sensory information processing 
after stimulus arrival in the cortex, whereas the later P2 and P3 peaks reflect a 
secondary, including active cognitive, processing of stimulus information (Chan and 
Davenport, 2009, 2010). Previous studies have found that in healthy controls, 
experimental induction of negative affect can lead to increased or decreased P3 
amplitudes depending on whether it is from internal or external modulating factors 
(von Leupoldt et al., 2010a; von Leupoldt et al., 2013; von Leupoldt et al., 2010b). In 
 addition, reduced P3 amplitudes have been observed in healthy individuals with 
higher state anxiety levels compared to those with lower state anxiety levels (von 
Leupoldt et al., 2011a). No effects of affective state or anxiety have been observed on 
the early RREP peaks. However, anxiety levels were usually tested in the non-clinical 
range. It remains unknown how clinical anxiety (i.e., as a disease state) impacts the 
higher cortical processing of respiratory perception. 
The purpose of this study is to investigate the effect of generalized anxiety disorder 
(GAD) on respiratory perception with the RREP technique using inspiratory 
occlusions. Based on the previous work (von Leupoldt et al., 2011), we hypothesized 
that the early Nf, P1, and N1 peaks would be unaffected in latencies and amplitudes, 
whereas the P3 peak latency and amplitude would be prolonged and reduced, 
respectively in the GAD patients relative to healthy controls. 
2. Materials and Methods 
2.1 Subjects 
The subjects were recruited from the psychiatric outpatient clinic in a medical center 
located in northern Taiwan. The patients were interviewed by a psychiatrist using the 
structured Mini-International Neuropsychiatric Interview (MINI), a short diagnostic 
interview for DSM-IV diagnosis (Sheehan et al., 1998).  All subjects reportedly had 
no history of respiratory, cardiovascular, or neurological disease. All subjects were 
instructed not to take any prescribed medication for at least 12 hours before the 
experiment. This study was approved by the Institutional Review Board of the Chang 
Gung Medical Foundation.  
2.2 Experimental Procedure 
The subject was provided with the consent form and explanation by the experimenter 
 prior to the study. After providing the written informed consent, the subject’s height 
and weight was measured, followed by a pulmonary function test (PFT) with standard 
spirometry (Cardinal Health Inc.). All subjects had to meet the criteria of Forced 
Expiratory Volume in 1 second (FEV1) of greater than 70% of the predicted 
normative value in order to participate in the study. After completing the PFT, the 
subjects filled out the Chinese-version questionnaires of the Beck Anxiety Inventory 
(Beck, 1990) and the Beck Depression Inventory II (Beck, 1996).  
2.3 Respiratory apparatus and the RREP recording 
The subject was instructed to sit comfortably and breathe through a mouthpiece with a 
nose clip positioned. The mouthpiece was connected to a two-way non-rebreathing 
valve (2600 series, Hans Rudolph Inc., Shawnee, KS). The inspiratory port of the 
non-rebreathing valve was connected to a customized occlusion valve (Hans Rudolph 
Inc., Shawnee, KS) manually controlled for closure through a trigger box. The closure 
was performed through triggering a solenoid for closing the occlusion valve with 
pressurized oxygen. For detailed information on the setup, please refer to the 
methodology paper of Chan et al.’s (2010) (Chan and Davenport, 2010). 
Mouth pressure was monitored and recorded at the center of the non-rebreathing valve 
through a differential pressure transducer connected to the pneumotachograph 
amplifier (1110 series, Hans Rudolph) and a PowerLab signal recording unit 
(ADInstruments Inc., Bella Vista, Australia). 
During the experiment, the subjects wore an electrode cap based on the international 
10-20 system. Electroencephalography was collected through a 40-channel EEG 
system (NuAmps, Compumedics Neuroscan, Inc., Charlotte, NC), referenced to the 
 bilateral mastoids behind the ears. The data was sampled at 1 kHz and the impedance 
level of each electrode was kept below 5 kΩ. The on-line band pass filter was set from 
0.3 Hz to 1 kHz.  
During the recording, inspiratory occlusions of 150 milliseconds (msec) were 
provided to the subjects randomly every two to four breaths after the onset of 
inspiration. At least 100 inspiratory occlusions were provided for data collection. The 
subjects were instructed to attend to the respiratory occlusions by mentally counting 
the number of inspiratory occlusions they perceived. After the recording, the subjects 
were asked to rate their level of dyspnea experienced during the experiment. 
Specifically, their level of shortness-of-breath (SOB) was assessed using the modified 
Borg scale (0= not at all SOB, and 10= maximal level of SOB).   
2.4 Data Analysis 
The offline data analysis was conducted with the BrainVision Analyzer 2 software 
(Brain Products GmbH., Gilching, Germany). After low-pass filtering at 50 Hz and 
ocular motor artifacts correction using the built-in algorithm, the EEG epochs were 
averaged. The epoch was defined and extracted from 200-msec before to 1000-msec 
after the trigger marker. The onset of occlusion was identified as the start of mouth 
pressure change using the Labchart Pro V7 (ADInstruments Inc., Bella Vista, 
Australia). The RREP peaks (Nf, P1, N1, and P3) were identified and their respective 
latencies and amplitudes were calculated. According to the past RREP studies in 
healthy nonsmoking adults (Chan and Davenport, 2010; Chou and Davenport, 2007; 
Davenport et al., 2007; von Leupoldt et al., 2011a; Webster and Colrain, 2000), the Nf 
peak was identified as the first negative peak maximal over the frontal cortices after 
25 msec post inspiratory occlusion; the P1 peak was identified as a positive peak 
 maximal over the centro-parietal area after 50 msec post inspiratory occlusion; the N1 
peak was identified as the 2
nd
 negative peak maximal over the vertex between 85 and 
135 msec after the occlusion; the P2 peak was identified as the most positive peak 
maximal over the vertex after the N1 peak between 160 and 230 msec after the 
occlusion; and the P3 peak was identified as the positive peak maximal over the 
parietal cortices between 250 and 350 msec after the occlusion. For the respiratory 
parameters, non-respiratory parameters, peak latencies and amplitudes, separate t-tests 
were performed to examine the difference between the GAD group and the control 
group. Additional correlation analyses (Pearson correlation coefficient) were 
performed to examine the relationships between ratings of SOB with the latencies of 
the RREP peaks. The critical p value was set at 0.05. 
3. Results 
3.1 Subject’s data 
Eighteen patients (9 females and 9 males) with the diagnosis of Generalized Anxiety 
Disorder and 11 age and gender matched healthy controls (4 females and 7 males) 
were recruited for this study. None of the subjects had a history of substance or 
alcohol abuse. Three of the 18 patients’ data were excluded because one subject failed 
to pass the PFT screening (FEV1 < 70% predicted value), and two other subjects’ 
brainwaves data contained significant amount of noise after data processing. The 
demographic data and the PFT results of the two groups of subjects are shown in 
Table 1. No difference was found for age, FEV1, FVC, and FEV1/FVC between the 
two groups. The GAD group showed significantly higher scores than the control 
group for the BDI-II and BAI questionnaires indicating significantly higher levels of 
depression as well as anxiety in the GAD patients, respectively (p = 0.0005 and p = 
 0.0002, respectively).  
3.2 RREP latencies and amplitudes 
Table 2 shows the averaged peak latencies and amplitudes for the RREP for both 
groups. The t-tests for every peak in latencies showed that there was no statistically 
significant difference between the healthy controls and the GAD groups for the Nf, P1, 
N1, and P2 peak. However, the GAD group showed a statistically longer P3 latency 
compared to the healthy control group (331±38 and 288±42 msec, respectively; p = 
0.018). There was no statistically significant difference in terms of the peak 
amplitudes for the Nf, P1, N1, and P2 peaks between the two groups. A one-tailed 
t-test revealed significantly smaller P3 peak amplitudes in the GAD group compared 
to the healthy group (p = 0.038). Figure 1 shows group averaged RREP waveforms of 
the healthy group and the GAD group.  
3.3 Dyspnea rating  
There was no statistical difference in the ratings of dyspnea between the healthy and 
GAD group. The averaged levels of SOB were 1.3±1.1 and 1.1±1.2 for the healthy 
controls and GAD group, respectively. Finally, correlation analyses between the SOB 
ratings and the peak latencies for the participants were calculated. A significant 
negative correlation between the Nf peak latency and the level of SOB (r= -0.6, p 
=0.018) was observed in the GAD group, not in healthy controls. There was also a 
significant negative correlation between the rated level of SOB and P1 peak latency in 
the GAD group (r= -0.59, p= 0.019). The correlations between the level of SOB and 
the N1, P2 or P3 peak latencies were not significant in both groups. 
4. Discussion 
 The present study showed that the inspiratory occlusion paradigm is a feasible and 
safe tool to use in measuring respiratory perception in GAD patients. The present 
result suggests that individuals with GAD, compared to the healthy controls, 
presented altered respiratory mechanosensation as demonstrated by a longer latency 
and reduced amplitude for the RREP P3 peak. Other variables including age and lung 
function parameters were not different between the two groups of subjects, but only 
the anxiety and depression levels were, as expected, significantly higher in the GAD 
group compared to the healthy controls. Therefore, the results of the present study 
suggest that clinically elevated anxiety in diseases such as GAD has a disease-specific 
impact on the neural processing of respiratory mechanosensation. The present data 
suggest that the disease does not have an impact on the amplitudes of the earlier 
RREP peaks Nf, P1, N1, and P2.  
Our results of the prolonged P3 latency and reduced P3 amplitude in the GAD group, 
compared to the healthy controls, are consistent with some notions given by the 
earlier RREP studies examining the effect of attention (Chan and Davenport, 2009; 
Harver et al., 1995; von Leupoldt et al., 2011a; von Leupoldt et al., 2010b; Webster 
and Colrain, 2000). In general, it has been suggested that P3 peak latency and 
amplitudes may be related to information processing speed and attentional resources 
allocation, respectively (Harver et al., 1995; Webster and Colrain, 2000). Specifically, 
Webster & Colrain (2000) found in their subject who presented a longer P3 latency 
during the counting RREP task also performed poorly in determining the duration of 
respiratory occlusions in the experiment. Harver et al. (1995) found that subjects 
presented both prolonged RREP P3 latency and reduced amplitudes when they 
ignored the occlusion stimulus by reading a magazine silently as compared to when 
they attended the occlusions by counting the occluded breaths. Importantly, our 
 current finding of reduced RREP P3 amplitudes in patients with GAD parallels 
previous results in healthy subjects. For example, negative affective states during 
emotional picture viewing have been shown to be associated with reduced RREP P3 
amplitudes (von Leupoldt et al., 2011b; von Leupoldt et al., 2010b). Notably, 
individuals with high state anxiety levels also showed reductions in the overall 
magnitudes of the long-latency RREP peaks compared to those individuals with low 
state anxiety levels, which is comparable to the present results in GAD patients. 
Moreover, Chan & Davenport (2009) found that, in a gating paradigm, the P3 
amplitudes of the first stimulus are increased significantly and therefore enhance the 
gating function by “filtering” in, or reallocating more necessary information related to 
the first stimulus for performing the attend task (Chan and Davenport, 2009). 
Although the current study does not have behavioral data such as reported number of 
occlusions counted to compare with the finding of longer latency and reduced 
amplitude of the P3 in the GAD group, it is reasoned that this delayed P3 could be due 
to slower information processing speed related to working memory which has long 
been reported in the literature about GAD (Rozenman et al., 2014). 
The findings of the preserved Nf and P1 amplitudes in the GAD group are consistent 
with some previous results from the earlier studies examining the effects of anxiety on 
the RREP in healthy nonsmoking individuals. There it was found that the exogenous 
peak amplitudes of Nf and P1 were unaffected by emotional manipulations or anxiety 
levels, respectively (Chan et al., 2012; Chenivesse et al., accepted; von Leupoldt et al., 
2011b; von Leupoldt et al., 2010b). In addition, our correlation analysis in the GAD 
patients showed a moderate-to-strong relationship between their Borg scale ratings of 
the SOB level and the latencies for Nf and P1 peaks. In other words, the more SOB 
 was perceived in GAD patients, the faster their processing of the respiratory stimulus 
was, indicating more automatic attention related resources were utilized for the 
respiratory stimulation. This suggests potential differences in the neural processing of 
respiratory sensations in subgroups of GAD patients with high versus low levels of 
perceived respiratory sensations, which requires further investigation. These 
relationships were not observed in the healthy control subjects. The finding about the 
healthy controls is in line with the previous study by von Leupoldt et al. (2011) where 
they found the early RREP peaks unaffected by anxiety in healthy individuals (von 
Leupoldt et al., 2011a). The present study extends the result of the previous study with 
the seemingly shorter information processing speed for the early peaks in those with 
more level of breathlessness under the GAD disease state. The finding together with 
the prolonged latency of P3 further help differentiate the sensory related from the 
cognitive related component in processing respiratory stimuli. The above findings 
may suggest that potential physiological changes in terms of afferent neural pathways 
or mechanisms exist in GAD, leading to altered neural activations in higher cortices 
including the pre-motor and somatosensory cortices.  
One limitation drawn from the present study is that all the GAD patients were referred 
from their regularly visited clinic and only stopped their prescribed medication for 
approximately 12 hours before entering the laboratory. The potential effect of residual 
anxiolytic medication such as benzodiazepines, selective serotonin- reuptake 
inhibitors (SSRI), and selective serotonin-norepinephrine reuptake inhibitors (SNRI) 
on the cortical processing of respiratory information are unknown. Therefore, future 
studies are encouraged to compare the RREP between medicated and unmedicated 
GAD patients in order to understand the effect of these medications.    
 5. Conclusions  
In summary, the present study suggests that GAD is associated with altered 
second-order processing of respiratory sensation, including slower cognitive 
information processing speed. Future studies with larger sample sizes are required to 
examine possible differences between subpopulations of GAD patients with regard to 
medication status, level of respiratory symptoms, and duration of GAD.  
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 Figure Legends 
Figure 1  
Group averaged waveform from the Cz electrode. The black solid line represents the 
averaged waveform in the healthy control (HC) group (N=11), and the gray solid line 
represents the averaged waveform in the GAD group (N=15). Note: latencies and 
amplitudes at Cz do not reflect the time window for the P3 peak, which was analyzed 
at centro-parietal electrodes.   
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 Table 2
a
  
 
 
a 
Averaged RREP Nf, P1, N1, P2, and P3 peak latencies and amplitudes (mean ± SD). 
The asterisk * indicates a statistical difference between the GAD group and the 
healthy control group (p < .05). 
 
 
 
 
 
 
Peak    Parameter GAD patients Healthy controls 
Nf  
 
P1  
Latency (msec) 
Amplitude (µV) 
Latency (msec) 
Amplitude (µV) 
63.5 ± 7.5 
-6.5 ± 2.3 
90.1 ± 16.0 
1.18 ± 0.15 
58.6 ± 8.9 
-7.5 ± 3.7 
80.8 ± 14.1 
1.83 ± 1.23 
N1  
Latency(msec) 
Amplitude (µV) 
115.1 ± 17.5 
-4.9 ± 2.8 
114.9 ± 12.6 
-5.1 ± 3.0 
P2 
 
P3  
Latency (msec) 
Amplitude (µV) 
Latency (msec) 
Amplitude (µV) 
173.7 ± 21.73 
5.41 ± 2.97 
331.4 ± 37.8 
6.0 ± 2.3 
170 ± 25.34 
5.29 ± 2.59 
288.4 ± 42.4* 
7.9 ± 2.6* 
    
    
    
